Argus lowered shares of Elevance Well being (NYSE:ELV – Free Report) from a purchase score to a maintain score in a analysis report report revealed on Friday morning, MarketBeat reviews.
A number of different analysis corporations have additionally weighed in on ELV. Stephens reissued an “obese” score and issued a $615.00 goal value on shares of Elevance Well being in a analysis word on Thursday, September fifth. Barclays lifted their value goal on shares of Elevance Well being from $611.00 to $622.00 and gave the corporate an “obese” score in a analysis report on Thursday, October tenth. Wells Fargo & Firm lowered their value goal on Elevance Well being from $600.00 to $593.00 and set an “obese” score on the inventory in a analysis word on Monday, July twenty second. Cantor Fitzgerald restated an “obese” score and set a $600.00 value goal on shares of Elevance Well being in a analysis report on Tuesday, October 1st. Lastly, Truist Monetary boosted their goal value on shares of Elevance Well being from $600.00 to $620.00 and gave the inventory a “purchase” score in a analysis word on Monday, July fifteenth. One analysis analyst has rated the inventory with a promote score, two have given a maintain score, 13 have assigned a purchase score and one has given a powerful purchase score to the inventory. Primarily based on knowledge from MarketBeat, Elevance Well being at present has a consensus score of “Reasonable Purchase” and a median value goal of $572.27.
Get Our Newest Report on Elevance Well being
Elevance Well being Inventory Down 3.1 %
Shares of NYSE ELV opened at $430.77 on Friday. The corporate has a debt-to-equity ratio of 0.58, a fast ratio of 1.49 and a present ratio of 1.49. The agency’s 50 day shifting common value is $526.74 and its 200 day shifting common value is $527.81. Elevance Well being has a 1 yr low of $397.98 and a 1 yr excessive of $567.26. The agency has a market cap of $100.12 billion, a P/E ratio of 16.28, a price-to-earnings-growth ratio of 1.08 and a beta of 0.82.
Elevance Well being (NYSE:ELV – Get Free Report) final posted its quarterly earnings knowledge on Thursday, October seventeenth. The corporate reported $8.37 earnings per share for the quarter, lacking the consensus estimate of $9.66 by ($1.29). Elevance Well being had a return on fairness of 20.64% and a internet margin of three.89%. The agency had income of $44.72 billion for the quarter, in comparison with analysts’ expectations of $43.47 billion. Throughout the identical quarter within the earlier yr, the agency posted $8.99 earnings per share. The corporate’s income for the quarter was up 5.3% on a year-over-year foundation. As a bunch, sell-side analysts anticipate that Elevance Well being will submit 37.26 earnings per share for the present yr.
Elevance Well being Pronounces Dividend
The agency additionally lately introduced a quarterly dividend, which will likely be paid on Friday, December twentieth. Shareholders of report on Thursday, December fifth will likely be issued a dividend of $1.63 per share. This represents a $6.52 annualized dividend and a yield of 1.51%. The ex-dividend date is Thursday, December fifth. Elevance Well being’s payout ratio is 24.64%.
Insider Exercise at Elevance Well being
In associated information, Director Ramiro G. Peru offered 753 shares of Elevance Well being inventory in a transaction dated Monday, August fifth. The inventory was offered at a median value of $531.52, for a complete transaction of $400,234.56. Following the completion of the sale, the director now owns 8,744 shares of the corporate’s inventory, valued at $4,647,610.88. The commerce was a 0.00 % lower of their possession of the inventory. The transaction was disclosed in a doc filed with the SEC, which is obtainable via this hyperlink. In different Elevance Well being information, EVP Charles Morgan Kendrick, Jr. offered 7,417 shares of Elevance Well being inventory in a transaction dated Friday, October 18th. The shares had been offered at a median value of $432.14, for a complete transaction of $3,205,182.38. Following the transaction, the manager vice chairman now immediately owns 8,423 shares of the corporate’s inventory, valued at $3,639,915.22. The commerce was a 0.00 % lower of their possession of the inventory. The sale was disclosed in a doc filed with the Securities & Trade Fee, which is accessible via the SEC web site. Additionally, Director Ramiro G. Peru offered 753 shares of the enterprise’s inventory in a transaction on Monday, August fifth. The shares had been offered at a median value of $531.52, for a complete worth of $400,234.56. Following the completion of the sale, the director now owns 8,744 shares within the firm, valued at $4,647,610.88. This represents a 0.00 % lower of their place. The disclosure for this sale may be discovered right here. 0.35% of the inventory is owned by company insiders.
Institutional Buying and selling of Elevance Well being
A number of hedge funds have lately added to or lowered their stakes within the firm. Massachusetts Monetary Providers Co. MA grew its place in shares of Elevance Well being by 34.0% within the second quarter. Massachusetts Monetary Providers Co. MA now owns 2,062,706 shares of the corporate’s inventory valued at $1,117,698,000 after buying a further 523,910 shares over the past quarter. M&G Plc purchased a brand new stake in Elevance Well being within the first quarter valued at about $203,389,000. Maj Make investments Holding A S acquired a brand new stake in Elevance Well being throughout the second quarter value about $173,753,000. First Eagle Funding Administration LLC lifted its stake in Elevance Well being by 15.5% within the second quarter. First Eagle Funding Administration LLC now owns 2,058,283 shares of the corporate’s inventory valued at $1,115,301,000 after shopping for a further 275,708 shares over the past quarter. Lastly, International Belongings Advisory LLC acquired a brand new place in Elevance Well being throughout the 1st quarter valued at about $109,435,000. Institutional traders and hedge funds personal 89.24% of the corporate’s inventory.
Elevance Well being Firm Profile
Elevance Well being, Inc, along with its subsidiaries, operates as a well being advantages firm in the US. The corporate operates via 4 segments: Well being Advantages, CarelonRx, Carelon Providers, and Company & Different. It gives a wide range of well being plans and providers to program members; well being merchandise; an array of fee-based administrative managed care providers; and specialty and different insurance coverage services and products, comparable to cease loss, dental, imaginative and prescient, life, incapacity, and supplemental medical health insurance advantages.
Featured Articles
Obtain Information & Scores for Elevance Well being Every day – Enter your e-mail handle under to obtain a concise every day abstract of the most recent information and analysts’ scores for Elevance Well being and associated firms with MarketBeat.com’s FREE every day e-mail publication.
